Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 3/2011

01.06.2011 | Research Article

Development of new concepts of non-adherence measurements among users of antihypertensives medicines

verfasst von: Lene Juel Kjeldsen, Lars Bjerrum, Hanne Herborg, Pia Knudsen, Charlotte Rossing, Birthe Søndergaard

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Objective To identify various types of non-adherence among users of antihypertensive medications by establishing components of adherence measures and use these components for measuring the prevalence of non-adherence. Setting Twelve community pharmacies from the Danish county of Funen. Method Users of antihypertensive medication were included in the study. 2,914 medication users received questionnaires by mail. Participating patients were asked to fill in two questionnaire regarding demographics, self-reported blood pressure, and various adherence measures. Two factor analyses were conducted based on responses to questions. Main outcome measures Medication-taking behaviour and self-efficacy (beliefs about ability and capacity to accomplish a task), respectively. Other measures of non-adherence collected by questionnaire were also addressed in the data for comparison of prevalence with the developed concepts. Results 1,426 (49%) participants answered the questionnaires. The analyses resulted in two sets of components: three adherence behaviour measures and two self-efficacy measures which showed similarities in concepts. The adherence behaviour measures included two concepts of intentional nonadherence (associated with aspects of self-regulation and effect concerns, respectively) and one measure of non-intentional non-adherence. Prevalence of the developed measures of behaviour related non-adherence ranged from 10.3 to 34.9% depending on which type of non-adherence measure was used. Established measures of non-adherence resulted in prevalence between 2.2 and 39.6%. Conclusions The study showed that concepts of non-adherence measurements could be determined including self-efficacy aspects, unintentional non-adherence and intentional non-adherence related to self-regulation and effect concerns respectively. The prevalence of the adherence behaviour components were found to be between 10.3 and 34.9%, which is in the range of expected values. Associations between the new concepts of non-adherence measurement and characteristics of nonadherers remain to be established and would be a subject for further studies.
Literatur
1.
Zurück zum Zitat Nissen NK, Rasmussen S. 2008 Heart Statistics-Focus on gender and social difference. <2008 HjerteStatistik-Fokus på køn og social forskelle>. Copenhagen: The Danish Heart Foundation and National Institute of Public Health University of Southern Denmark; 2008. Nissen NK, Rasmussen S. 2008 Heart Statistics-Focus on gender and social difference. <2008 HjerteStatistik-Fokus på køn og social forskelle>. Copenhagen: The Danish Heart Foundation and National Institute of Public Health University of Southern Denmark; 2008.
2.
Zurück zum Zitat Adherence to long-term therapies: evidence for action. Noncommunicable diseases and mental health adherence to long term therapies project. Geneva: World Health Organisation; 2003. ISBN 92 4 154599 2. Adherence to long-term therapies: evidence for action. Noncommunicable diseases and mental health adherence to long term therapies project. Geneva: World Health Organisation; 2003. ISBN 92 4 154599 2.
4.
Zurück zum Zitat The 6th report of the joint national commission on high blood pressure. Arch Int Med 1997;157: 2413–56. The 6th report of the joint national commission on high blood pressure. Arch Int Med 1997;157: 2413–56.
5.
Zurück zum Zitat Urquhart J. The odds of the three nons when an aptly prescribed medicine isn’t working: non-compliance, non-absorption, non-response. Br J Clin Pharmacol. 2002;54:212–20.PubMedCrossRef Urquhart J. The odds of the three nons when an aptly prescribed medicine isn’t working: non-compliance, non-absorption, non-response. Br J Clin Pharmacol. 2002;54:212–20.PubMedCrossRef
6.
Zurück zum Zitat Ho PM, Magid DJ, Shetterly SM, Olson KL, Peterson PN, Masoudi FA, et al. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Arch Intern Med. 2008;168:271–6.PubMedCrossRef Ho PM, Magid DJ, Shetterly SM, Olson KL, Peterson PN, Masoudi FA, et al. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Arch Intern Med. 2008;168:271–6.PubMedCrossRef
8.
Zurück zum Zitat Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120:1598–605.PubMedCrossRef Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120:1598–605.PubMedCrossRef
9.
Zurück zum Zitat Stason WB. Compliance, quality of life and cost effectiveness. Curr Hypertens Rep. 1999;1:471–4.PubMedCrossRef Stason WB. Compliance, quality of life and cost effectiveness. Curr Hypertens Rep. 1999;1:471–4.PubMedCrossRef
10.
Zurück zum Zitat Cleemput I, Kesteloot K. Economic implications of non-compliance in health care. Lancet. 2002;359:2129–30.PubMedCrossRef Cleemput I, Kesteloot K. Economic implications of non-compliance in health care. Lancet. 2002;359:2129–30.PubMedCrossRef
11.
Zurück zum Zitat Jokisalo E, Kumpusalo E, Enlund H, Halonen P, Takala J. Factors related to non-compliance with antihypertensive drug therapy. J Hum Hypertens. 2002;16:577–83.PubMedCrossRef Jokisalo E, Kumpusalo E, Enlund H, Halonen P, Takala J. Factors related to non-compliance with antihypertensive drug therapy. J Hum Hypertens. 2002;16:577–83.PubMedCrossRef
12.
Zurück zum Zitat Schaffer SD, Yoon SJ. Nurse Pract. 2001;26(12):44, 50, 52, 54. Review. Schaffer SD, Yoon SJ. Nurse Pract. 2001;26(12):44, 50, 52, 54. Review.
13.
Zurück zum Zitat Horne R, Clatworthy J, Polmear A, Weinman J. Do hypertensive patients’ beliefs about their illness and treatment influence medication adherence and quality of life? J Hum Hypertens. 2001;Suppl 1:65–8. Horne R, Clatworthy J, Polmear A, Weinman J. Do hypertensive patients’ beliefs about their illness and treatment influence medication adherence and quality of life? J Hum Hypertens. 2001;Suppl 1:65–8.
14.
Zurück zum Zitat Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the necessity–concerns framework. J Psychosom Res. 2008;64:41–6.PubMedCrossRef Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the necessity–concerns framework. J Psychosom Res. 2008;64:41–6.PubMedCrossRef
15.
Zurück zum Zitat Rickles N, Svarstad B. Relationships between multiple self-reported nonadherence measures and pharmacy records. Res Social Adm Pharm. 2007;3:363–77.PubMed Rickles N, Svarstad B. Relationships between multiple self-reported nonadherence measures and pharmacy records. Res Social Adm Pharm. 2007;3:363–77.PubMed
16.
Zurück zum Zitat Sumartojo E. When tuberculosis treatment fails. A social behavioural account of patient adherence. Am Rev Respir Dis. 1993;147:1311–20.PubMed Sumartojo E. When tuberculosis treatment fails. A social behavioural account of patient adherence. Am Rev Respir Dis. 1993;147:1311–20.PubMed
17.
Zurück zum Zitat Matza LS, Park J, Coyne KS, Skinner EP, Malley KG, Wolever RQ. Derivation and validation of the ASK-12 adherence barrier survey. Ann Pharmacother. 2009;43:1621–30.PubMedCrossRef Matza LS, Park J, Coyne KS, Skinner EP, Malley KG, Wolever RQ. Derivation and validation of the ASK-12 adherence barrier survey. Ann Pharmacother. 2009;43:1621–30.PubMedCrossRef
18.
Zurück zum Zitat Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB. The concordance of self-report with other measures of medication adherence: A summary of the literature. Med Care. 2004;42:649–52.PubMedCrossRef Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB. The concordance of self-report with other measures of medication adherence: A summary of the literature. Med Care. 2004;42:649–52.PubMedCrossRef
19.
Zurück zum Zitat Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray MD. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother. 2009;43:413–22.PubMedCrossRef Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray MD. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother. 2009;43:413–22.PubMedCrossRef
20.
Zurück zum Zitat Vrijens B, Urquhart J. Patient adherence to prescribed antimicrobial drug dosing regimens. J Antimicrob Chemother. 2005;55:616–27.PubMedCrossRef Vrijens B, Urquhart J. Patient adherence to prescribed antimicrobial drug dosing regimens. J Antimicrob Chemother. 2005;55:616–27.PubMedCrossRef
21.
Zurück zum Zitat Svarstad BL, Chewning BA, Sleath BL, Claesson C. The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37:113–24.PubMedCrossRef Svarstad BL, Chewning BA, Sleath BL, Claesson C. The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37:113–24.PubMedCrossRef
22.
Zurück zum Zitat Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.PubMedCrossRef Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.PubMedCrossRef
23.
Zurück zum Zitat Ogedegbe G, Mancuso CA, Allegrante JP, Charlson ME. Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients. J Clin Epidemiol. 2003;56:520–9.PubMedCrossRef Ogedegbe G, Mancuso CA, Allegrante JP, Charlson ME. Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients. J Clin Epidemiol. 2003;56:520–9.PubMedCrossRef
24.
Zurück zum Zitat Insel KC, Reminger SL, Hsiao C-P. The negative association of independent personality and medication adherence. J Aging Health. 2006;18:407–18.PubMedCrossRef Insel KC, Reminger SL, Hsiao C-P. The negative association of independent personality and medication adherence. J Aging Health. 2006;18:407–18.PubMedCrossRef
25.
Zurück zum Zitat Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of the medication. Psychol Health. 1999;14:1–24.CrossRef Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of the medication. Psychol Health. 1999;14:1–24.CrossRef
26.
Zurück zum Zitat Horne R, Hankins M, Jenkins R. The satisfaction with information about medicines scale (SIMS new measurement tool for audit and research. Qual Health Care. 2001;10:135–40.PubMedCrossRef Horne R, Hankins M, Jenkins R. The satisfaction with information about medicines scale (SIMS new measurement tool for audit and research. Qual Health Care. 2001;10:135–40.PubMedCrossRef
27.
Zurück zum Zitat Weintraub M. Intelligent noncompliance with special emphasis on the elderly. Contemp Pharm Pract. 1981;4:8–11.PubMed Weintraub M. Intelligent noncompliance with special emphasis on the elderly. Contemp Pharm Pract. 1981;4:8–11.PubMed
28.
Zurück zum Zitat Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ. 2008;336:1114–20.PubMedCrossRef Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ. 2008;336:1114–20.PubMedCrossRef
29.
Zurück zum Zitat Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003;26:1408–12.PubMedCrossRef Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003;26:1408–12.PubMedCrossRef
30.
Zurück zum Zitat Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21:1074–90.PubMedCrossRef Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21:1074–90.PubMedCrossRef
Metadaten
Titel
Development of new concepts of non-adherence measurements among users of antihypertensives medicines
verfasst von
Lene Juel Kjeldsen
Lars Bjerrum
Hanne Herborg
Pia Knudsen
Charlotte Rossing
Birthe Søndergaard
Publikationsdatum
01.06.2011
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 3/2011
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-011-9509-y

Weitere Artikel der Ausgabe 3/2011

International Journal of Clinical Pharmacy 3/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.